Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. COPETTI
Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
Afro-Egyptian Journal of Infectious and Endemic Diseases
Rosacea Fulminans Related to Pegylated Interferon Alpha-2b and Ribavirin Therapy
Acta Dermato-Venereologica
Dermatology
Medicine
Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics
AIDS
Infectious Diseases
Allergy
Immunology
Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure
Hepatology
Medicine
Hepatology
Renal Dysfunction With Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin Therapy
Acta Hepatologica Japonica
Hepatology
Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis C Patients Before and After Pegylated Interferon Alfa-2b Plus Ribavirin Therapy
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C
Archives of Internal Medicine
Peg-Interferon /Ribavirin With and Without Rituximab for Hepatitis C-Related Mixed Cryoglobulinemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection
Eastern Mediterranean Health Journal
Medicine
